INDIA’S IPO INTELLIGENCE PLATFORM

Track every
IPO move.

One clean place for Indian IPO news, NSE & BSE listings, GMP context, allotment updates and deeper research.

NSE + BSEIndian market coverage
SME + MainboardOne IPO dashboard
DailyNews & research updates
PRIMARY MARKET DESKINDIA
NEW ISSUEIPOTRACKER
NSEBSESME
PRICE BAND₹ — ₹
ISSUE SIZE₹ CR
STATUSOPEN / UPCOMING
NewsGMPAllotmentListingResearch
IPO DESKMainboardNSE + BSE TRACKOpen IssuesLive WATCHAllotmentsDaily RESEARCHDRHP NotesPremium MARKETSME IssuesTracked LISTINGDay UpdatesFast IPO DESKMainboardNSE + BSE TRACKOpen IssuesLive WATCHAllotmentsDaily RESEARCHDRHP NotesPremium MARKETSME IssuesTracked LISTINGDay UpdatesFast

From opening bell to listing day, every IPO deserves more than noise.

Updated Daily · IST

IPO Calendar

View Full Calendar →
Hyundai
Mainboard · NSE · BSEUpcoming

Hyundai India Limited

Automobiles · Issue Size: ₹27,870 Cr

Price Band₹1,865 – ₹1,960
Lot Size7 shares
Open15 Oct 2026
Listing22 Oct 2026
↗   GMP: +₹110 (+5.6%)Read Research 🔒
Open Now

Ola Electric Mobility

Mainboard

Price₹72–₹76
Closes18 Oct 2026
4.28x subscribed
Closing Soon

KRN Heat Exchanger

BSE SME

Price₹220–₹230
Closes12 Oct 2026
2.1x subscribed
Listing Today

Vibhor Steel Tubes

Issue ₹72

Est. listing₹87
↗ +20.8%
IPO Desk · NSE · BSE

IPO News

View All News →
National Stock Exchange building in Mumbai
NSE · MUMBAI

Indian IPOs. One market desk.

PRIMARY MARKETIPO

Open issues · subscription · allotment · listing

NSE+BSE
Bombay Stock Exchange building in Mumbai
BSE · DALAL STREET

News beyond the headline.

Exchange photography: Ganesh Dhamodkar / Wikimedia Commons (NSE, CC BY-SA 4.0) · Niyantha Shekhar / Wikimedia Commons (BSE, CC BY 2.0).

Premium Only

Research That Pays

Deep-dive IPO research built to help investors separate story from substance.

Research
Deep Dive · Mainboard

Hyundai India IPO: Is India’s Biggest Auto IPO Worth the Valuation?

Business quality, peer valuation, risks, issue structure and what the DRHP is really telling investors.

Unlock Full Report →
Valuation Note

When premium pricing becomes a risk, not a signal.

Read report 🔒
DRHP Forensics

The five lines most IPO investors skip — and shouldn’t.

Read report 🔒
SME Research

How to screen liquidity and promoter risk before applying.

Read report 🔒
Research Notes · Every Monday

Investor Blog

IPO Playbook

How to Read an IPO DRHP Like an Institutional Analyst

A practical framework for spotting dilution, related-party risks, working-capital stress and aggressive assumptions before you apply.

Read the playbook →
Key Takeaway

GMP is context. Cash flows are evidence.

Key Takeaway

Fresh issue and OFS tell very different capital stories.

Actionable Insight

Build a repeatable checklist before every IPO application.

Choose Your Access

Simple Plans.

Start free. Upgrade when deeper research becomes part of your process.

Free

₹0

Stay current with essential IPO information.

  • IPO calendar
  • IPO news
  • Basic GMP view
  • Listing updates
Start Free
Professional

₹2,499/year

Expanded intelligence for serious IPO market tracking.

  • Everything in Premium
  • SME + Mainboard coverage
  • Valuation comparison notes
  • Downloadable reports
Contact Us
18,400+Active Subscribers
240+IPOs Covered
4Market Segments
94%Research Accuracy
Subscriber Stories

What Investors Say

18,000+ investors across India trust IPOInsight for IPO decisions. From first-time applicants to HNI portfolios.

The research is crisp, data-led and easy to act on. I stopped applying to every IPO and started being selective.

Arjun MehtaActive Investor · Premium

The calendar and GMP view save time, but the research notes are what make the subscription useful.

Neha ShahRetail Investor · Premium

I like that risks are shown as clearly as the positives. It feels more like research than promotion.

Rohit JainHNI Investor · Professional

Start Investing
Smarter.

View Pricing Plans

Every IPO. Every segment. One platform.

Updated daily · IST
Contact IPOInsight

Have an IPO
question?

Send your enquiry and our team can respond on IPO research, subscriptions, website access or general support.

✓ Name & mobile✓ Email enquiry✓ GDPR consent
CONTACT FORMUsually replies within 1 business day

    nnnnn

    n

    n